Cardiac safety strategies. 25-26 October 2005, the Radisson SAS Hotel, Nice, France

Expert Opinion on Drug Safety
Gilles Hanton, Lorraine Tilbury

Abstract

This meeting was organised by IIR Life Sciences. It was chaired by Brian Guth, (head of General Pharmacology at Boehringer Ingelheim Pharma) and brought together scientists and clinicians from the pharmaceutical industry, university and regulatory agencies. The meeting presented emerging trends in cardiac safety, including its regulatory context pertaining to ICH S7A, S7B and E14. ICH S7A and S7B highlight the importance of the hERG test and telemetric studies in non-rodents. ICH E14 describes the clinical 'thorough QT study' that is required by the FDA for any new drug. Marked physiological variability in QT interval over time can be observed, partly as a result of fluctuation in autonomic tone. Beat-to-beat QT variability and T-wave morphology should be considered as a part of an integrated estimate of proarrhythmic risk. A case study illustrated the predictivity of preclinical data for proarrhythmic risk in humans, showing the importance of evaluating QT effects in patients to establish a safety margin.

References

Nov 25, 2000·Journal of the American College of Cardiology·M Malik, V N Batchvarov
Jan 16, 2002·Current Opinion in Cardiology·Charles Antzelevitch, Wataru Shimizu
Jan 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Erdulfo J GaleanoMitsuhiro Yokoyama
Dec 5, 2003·Trends in Pharmacological Sciences·Luiz BelardinelliMarc A Vos
Oct 20, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah

❮ Previous
Next ❯

Citations

Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Blaine W Phillips, Jeremy M Crook
Oct 22, 2009·Journal of Clinical Pharmacology·Sunny ChapelRichard L Lalonde
Jun 29, 2007·Drugs in R&D·Gilles Hanton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.